Drugs Made In America Acquisition DMIIR
NASDAQ DMIIR
$0.07 -0.01 (-7.04%)
As of: Sep 2, 2026 · 12:48 PM EDT

Drugs Made In America Acquisition (DMIIR) Change in Account Payables (2025)

Drugs Made In America Acquisition (DMIIR) posted quarterly Change in Account Payables of $94767.0 for Q4 2025.

Analysis

Drugs Made In America Acquisition (DMIIR) Change in Account Payables (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has reported Change in Account Payables for 1 consecutive years, with $94767.0 the latest figure, recorded in Q4 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Cluster Group Holdings 8.00 Bn 8.00 Bn - -
2 Agriculture & Natural Solutions Acquisition 853.42 Mn 853.17 Mn - -
3 K&F Growth Acquisition 836.15 Mn 836.15 Mn - -
4 Armada Acquisition 665.67 Mn 665.62 Mn - -
5 Pioneer Acquisition I 652.74 Mn 652.27 Mn - 21,444.00
6 Oxley Bridge Acquisition 652.11 Mn 652.11 Mn - 34,416.00
7 Titan Acquisition 651.43 Mn 941.85 Mn - -
8 GSR IV Acquisition 622.22 Mn 622.22 Mn - -
9 Launch One Acquisition 618.70 Mn 618.70 Mn - -
10 Drugs Made In America Acquisition 5.10 Mn 5.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 94,767.00
Sep 30, 2025 2,429.00